VERMOX

This brand name is authorized in Canada, Cyprus, Estonia, Ireland, Israel, Lithuania, Malta, Mexico, New Zealand, Poland, Romania, United Kingdom, United States, South Africa

Active ingredients

The drug VERMOX contains one active pharmaceutical ingredient (API):

1 Mebendazole UNII 81G6I5V05I - MEBENDAZOLE

In vitro and in vivo work suggests that mebendazole blocks the uptake of glucose by adult and larval forms of helminths, in a selective and irreversible manner. Inhibition of glucose uptake appears to lead to endogenous depletion of glycogen stores within the helminth. Lack of glycogen leads to decreased formation of ATP and ultrastructural changes in the cells. Read about Mebendazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VERMOX Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P02CA01	Mebendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00556734
Country: EE	Ravimiamet	Identifier(s): 1007222, 1781894, 1832486, 1837076
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139694, 147546, 147549, 163304, 166803, 166805, 23895, 23912
Country: IE	Health Products Regulatory Authority	Identifier(s): 64033, 73938
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1432, 4335
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1012291, 1051993, 1074444, 1077617, 1077706, 1078744, 1083608, 1084788
Country: MT	Medicines Authority	Identifier(s): MA018/01201, MA018/01202, PI908/11801A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 80029, 84402
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15089, 2310, 2311
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100048506, 100070285, 100292689, 100324627, 100352345
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W11305001
Country: US	FDA, National Drug Code	Identifier(s): 50458-675, 50580-070
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/12/0058, G/12/105, K/12/206, W/12/42